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Abstract  1 
Clinical Genetics services provide a diagnostic, counselling and genetic testing service 2 
for children and adults affected by, or at risk of, a genetic condition, most of which are 3 
rare, or genetically heterogeneous. Appropriate triage of referrals is crucial to ensure 4 
the most urgent referrals are seen as quickly as possible, without negatively impacting 5 
the waiting times of less urgent cases. We aimed to examine triage practice in 6 6 
Clinical Genetic centres across the UK and Ireland. Thirteen simulated referrals were 7 
drafted based on common referrals to Clinical Genetics. Copies of each referral were 8 
forwarded to each centre, where 10 nominated clinicians were asked to triage each 9 
referral. Triaged referrals were returned to the coordinating author for analysis. An 10 
electronic questionnaire was contemporaneously completed by clinical leads in each 11 
unit to gather local demographic details and local operating procedures relevant to 12 
triage. Widespread inconsistencies were noted both within and between units, with 13 
respect to acceptance of referrals to services, prioritisation, and designated clinic type. 14 
Referral rates, staffing levels, and waiting lists varied widely between units. 15 
Inconsistencies observed between units are likely influenced by a number of factors 16 
including; staffing levels, referral rates, and average family size. Inconsistency within 17 
units likely reflects the complex nature of many Clinical Genetic referrals and triage 18 
guidelines should help improve decision making in this setting. 19 
  20 
Introduction 21 
Clinical Genetics services provide a diagnostic, counselling and genetic testing service 22 
for children and adults affected by, or at risk of, a genetic condition[1]. Referrals come 23 
from almost all specialties, from primary, secondary and tertiary centres[2]. The 24 
geographical catchment area, and indications for referral (from neonatal to adult; 25 
dysmorphology, and referrals from all subspecialties) covered by Clinical Genetics 26 
centres is wide.  27 
Increasingly broad genetic testing has led to discovery of novel disease genes, and new 28 
genotype-phenotype associations (figure 1)[3]. This has positively impacted diagnostic 29 
yield in patients with disorders related to previously undefined genetic aetiology (e.g. 30 
epilepsy, sudden adult death); but has also led to increased detection of variants of 31 
uncertain significance[4, 5], and of variants in genes not previously known to be 32 
assoĐiated ǁith a paƌtiĐulaƌ pheŶotype ;͞geŶes of uŶĐeƌtaiŶ sigŶifiĐaŶĐe͟Ϳ[6].  Such 33 
variants generate massive clinical workload, and often require reviewing multiple 34 
family members to facilitate segregation analysis; or may require multiple patient 35 
encounters to facilitate collection of different sample types for functional studies (e.g. 36 
skin or muscle biopsy, biochemical testing). A single referral may therefore generate 37 
many days-weeks of clinical work. Furthermore, absolute numbers of referrals may be 38 
a poor reflection of the workload of a unit, depending on the complexity of the case-39 
mix [7]. Benign, likely benign or uncertain variants are frequently picked up by array 40 
CGH[8], a test routinely used by general paediatricians. As non-Geneticists grapple 41 
with increasingly complex genetic test reports they request advice to help interpret 42 
the report; while the actual presenting complaint in the patient may have been 43 
considered too trivial to refer in the past. Previous audits suggest referrals to explain 44 
normal benign or likely benign human variation account for 10% of general referrals 45 
[9].  46 
The specialty mainly receives non-urgent out-patient referrals, however, pre-natal 47 
referrals, or referrals for patients approaching end of life require prompt assessment. 48 
Demand for urgent access to genetic testing is growing where results might influence 49 
management. Increasingly, targeted therapies are being licenced for use in patients 50 
with germline or somatic genetic variation, particularly in treatment of cancer (e.g. 51 
PARP inhibitors, ATR inhibitors, small molecule kinase inhibitors)[10, 11].  Public and 52 
media awareness has also driven demand, both those affected or at risk of a familial 53 
genetic disorder[12]. Increasing cost-efficiency of testing has led to an interest in 54 
population-based screening for genetic disorders[13-15], and has driven direct-to-55 
consumer testing, with predicted market value of up to $310 million by 2022 [16, 17]. 56 
Consequently, this puts increasing stress on under-resourced genetic services.   57 
Genetic counsellors are highly skilled clinical professionals, usually from scientific or 58 
nursing backgrounds, with specialist training in genetic counselling[18]. Not all 59 
countries employ genetic counsellors, but they form a core part of the Clinical Genetics 60 
teams in the UK and Ireland[19]. In most genetic centres in the UK and Ireland, 61 
Consultant Geneticists review undiagnosed or complex patients, while genetic 62 
counsellors review patients at risk of a known familial genetic disorder, to offer pre-63 
symptomatic predictive testing. Some centres utilise a co-counselling approach 64 
involving both types of professional[19], while in other centres, patients have an initial 65 
͞pƌe-ĐliŶiĐ͟ ǁith a genetic counsellor, followed thereafter by consultant-led 66 
interaction. It is well-recognised that there is a significant shortage of both Genetic 67 
Counsellors and Consultant Clinical Geneticists internationally, particularly in Ireland 68 
and England [20-22]. Appropriate triage of referrals is a critical factor in trying to 69 
address demands on the service in the face of limited resources; to ensure the most 70 
urgent referrals are seen as quickly as possible, without negatively impacting the 71 
waiting times of less urgent cases. To ensure optimal provision of services, the Clinical 72 
Genetics Society has considered a number of common referrals that do not need face-73 
to-face consultation in a Clinical Genetics Centre[23]. Centres have also adopted local 74 
policies to reject referrals pertaining to conditions where specialist clinics exist in the 75 
region [24]. In Centre 1, for example, all referrals related to patients with inherited 76 
cardiac pathologies are deferred to the Cardiology service. In Centre 3, referrals 77 
related to common paediatric conditions such as Down Syndrome or Spina Bifida are 78 
managed by letter to the patient, without offering patient a formal consultation. This 79 
may partly explain inter-departmental differences.  80 
However, as referrals may pertain to any one of thousands of different rare disorders, 81 
standardisation of referrals is very difficult. We aimed to review the practice of triage 82 
in Clinical Genetics centres in the UK and Ireland using high-fidelity simulated referrals.  83 
Methods           84 
A consultant geneticist in each centre was identified and asked to co-ordinate the 85 
study locally. Participants were asked to complete a short questionnaire to establish 86 
local demographics and local practice at their respective centre. Data was collected 87 
with respect to factors that could potentially influence triage practice, including 88 
staffing level, waiting lists, catchment area and population size, clinician responsible 89 
for triage, and number of referrals per year.  90 
Thirteen simulated referrals were designed (by TMcV and SAL). Ten were based on 91 
genuine referrals, with patient, referring Doctor and hospital identifiers removed, and 92 
details changed slightly so as to maintain confidentiality in line with European General 93 
Data Protection Regulation legislation.  The remaining 3 (referral no. 4, 7 & 13) were 94 
composed by the authors based on common referrals to a Clinical Genetics service. All 95 
were printed on headed notepaper of a fictitious hospital (Supplementary Figure 1), 96 
and 10 hard copies were posted to each centre. This was to endeavour to create high-97 
fidelity simulated referrals on the expectation that the research triage would be a true 98 
reflection of genuine triage [25, 26]. The nature of the 13 referrals can be seen in table 99 
1. Participants were told these were simulated referrals. We deliberately mis-spelt 100 
certain words, and inserted iŶfoƌŵatioŶ ƌegaƌdiŶg a patieŶt’s pƌegŶaŶĐy iŶ the middle 101 
of a referral rather than placing emphasis on the urgency of the referral, reflecting 102 
frequent errors in referrals from practitioners unfamiliar with genetic conditions and 103 
implications of such disorders for progeny of affected individuals, increasing fidelity of 104 
the simulation.  105 
Participants were asked to triage each referral by type of appointment; urgency; 106 
designated clinician, etc, using a standardised triage stamp (figure 2).  Completed 107 
triage forms were posted back to the lead author in the coordinating centre. Data 108 
were tabulated and analysed using SPSS v23.   109 
Results 110 
Participants 111 
In total, 53 clinicians from 6 centres participated in the simulated triage exercise. 112 
Participants included 27 consultants (51%), 19 Genetic Counsellors (36%) and 7 (13%) 113 
Specialist Registrars (table 2). All participants from centre 5 were consultants as local 114 
practice dictates that only consultants perform triage. In Centres 4 and 6, certain 115 
consultants perform triage for both General and Cancer cases, while others triage only 116 
one category or the other. Depending on their local practice, some clinicians declined 117 
to triage certain simulated referrals. 118 
Significant variability in the process of triage was noted across the six centres. In three 119 
centres (Centres 1, 4 and 5), triage of general referrals was undertaken by consultants 120 
only, and in the other three centres, by consultants and GCs. Triage of cancer referrals 121 
was, conversely, done by GCs only in three centres (Centres 1,2 and 4), and by 122 
consultant only in Centres 5 and 6.  All centres accept referrals by letter. Five centres 123 
accept electronic referrals, and four accept referral by fax (table 3).124 
Between centres, there was variability in the number of referrals per 1000 of population per 125 
annum (0.84-3/1000), and the number of referrals per consultant and per staff member, 126 
which could not be explained by average family size. Centre 3 and Centre 1 had almost 127 
equivalent numbers of referrals despite >2.5-fold difference in the size of population.  128 
There were clear discrepancies in staffing numbers with Centre 2 being relatively well 129 
staffed and Centre 3 being very poorly staffed, with respect to both consultant and GC 130 
workforce. The ratio of referrals/staff member was lowest in Centre 4, and highest in Centre 131 
1. The proportion of referrals managed without a face-to-face appointment was highest in 132 
Centre 4 and lowest in Centre 1 (8-38). 133 
Acceptance of referrals to service 134 
Considering all clinicians, widespread variability in triage was noted (Figure 3 (3a)). Only 3 135 
(23%) of the referrals had >80% consensus about whether  the referral should be accepted 136 
for a consultation. There was complete or almost complete consistency (>80% consensus) 137 
with the triage decision for five referrals (referrals 1,3, 5, 6 and 10) amongst consultants 138 
(Figure 3 (3b)), and consensus of 60-80% for three others (referrals 9, 12 and 13).  139 
 140 
Significant inconsistency was noted for the other referrals, with some consultants offering a 141 
face to face appointment, and others managing the same  referrals by providing an 142 
information letter or telephone consultation to the patient. Other clinicians elected to reject 143 
the referral and provide referrer with information about onward management of the 144 
patient, without direct patient contact.  145 
 146 
When triage performed by Genetic counsellors was considered, only two referrals (referral 1 147 
and 10) had >80% consensus regarding type of consultation offered. Referral 3,4 and 6 148 
showed 60-80% consensus (Figure 3 (3c)). Consensus between and within centres are 149 
demonstrated in supplementary figures 2-12. 150 
 151 
Prioritisation of Referrals 152 
Of those referrals offered face to face appointments,  significant variability in priority and 153 
designated clinician was also noted (supplementary table 1). In a significant number of 154 
cases, clinicians did not specify priority/designated clinician (excluded).  155 
 156 
The referral with the most agreement between clinicians was a simulated urgent referral of 157 
a pregnant woman with a family history of Duchenne muscular dystrophy. Forty-eight 158 
clinicians triaged this referral, and all accepted the referral to service. 47/48 specified the 159 
priority of the referral as priority (1 did not specify). There was inconsistency in determining 160 
designated clinician, with 26 (57%) triaging the case for GC appointment, and 20 (43%) for 161 
consultant (2 did not specify).  162 
Consistency within Centres (Supplementary Table 1) 163 
Where appointments were offered, 100% consistency was noted for prioritisation of five 164 
referrals, including referral 10 as priority; as well as referrals 8, 9, 111 and 13 which were 165 
deemed routine by all participants. Certain centres were more consistent than others with 166 
respect to prioritisation of those referrals for which face-to-face appointments were 167 
offered. Clinicians in Centre 2 agreed on priority of an additional two referrals of those 8 168 
                                                          
1 In one centre, referrals pertaining to Hereditary Haemochromatosis are deferred to Gastroenterology so are 
not offered appointments in the Clinical Genetics unit  
offered face to face appointments in that centre (25%), Centre 3 2/5 (40%), Centre 5, Centre 169 
6 and Centre 1 another 4/7 (57%), and Centre 4 5/8 (63%).  170 
With respect to designated clinicians, inconsistency across each referral was noted. In 171 
Centre 3, of 8 referrals offered appointments, there was agreement between participants 172 
there for designated clinician in 5 (63%) appointments. In Centre 2 and Centre 4, all referrals 173 
would be offered appointments by at least one clinician2, but there was agreement in these 174 
centres with respect to designated clinician in only 2 (15%) cases.  175 
                                                          
2 Referral 7 was offered an appointment by only one clinician in Centre 2, and by two clinicians in Centre 4 
 176 
Discussion 177 
Clinical triage is an important step in all specialties, aiming to ensure prioritisation of 178 
referrals and maintain equity of access. Our study has shown widespread inconsistencies in 179 
managing common referral scenarios both within and between six Clinical Genetic units in 180 
the Republic of Ireland and the United Kingdom. Inconsistencies were noted with respect to 181 
acceptance of referrals to service, prioritisation of referrals, and type of clinic to which 182 
referral was assigned 183 
Discrepancy between centres with respect to type of consultation offered to patients may 184 
be attributed to hospital management systems; in the Republic of Ireland; referrals that 185 
were not offered a face-to-face consultation were deemed rejected, despite providing the 186 
patient with information directly, whereas similar practices in centres in UK system were 187 
acknowledged, and remunerated, as clinical activity. However, this does not explain the 188 
differences between clinicians within centres.  Differences in priority assigned to cases may 189 
be influenced by waiting lists and staffing, which vary between centres. It is possible that 190 
decision-making with respect to assignment of cases to Consultant or Genetic Counsellor 191 
may be influenced by the level of expertise of staff within the unit.  192 
Traditionally, research on triage has concentrated on pre-hospital, trauma, acute or 193 
emergency care settings[27-31]. Assessment of triage in tertiary referrals specialties has also 194 
concentrated on optimising management in the acute scenario[32]. Appropriate triage in 195 
tertiary referral setting is important to ensure equity of care, timely access based on need 196 
and an ability to manage waiting lists in accordance with staffing levels[33-36]. Prioritisation 197 
of the most urgent referrals is critical when waiting lists deteriorate and timely access to 198 
care is at risk[37-39]. Each speciality will have specific drivers that influence the ebb and 199 
flow of referrals. Triage decision making in Clinical Genetics is driven by many factors 200 
related to the centre in question (e.g. staffing levels,  skill mix, waiting list times, population 201 
demographics), the patient to which referral pertains (e.g. pregnant patient, patient 202 
approaching end of life, patient age, patient at risk of inheriting familial variant), or nature 203 
of the referral itself (request for genetic information to determine treatment, advice to 204 
interpret genetic test results, adequacy of information on referral letter). 205 
Factors known to influence referral rates include education of referrers, the genetics 206 
workforce, and logistic factors[40, 41]. We noted regional differences in referral rates/1000 207 
population, which have not previously been described. A number of factors may account for 208 
these apparent differences. Genetic disorders may be more prevalent in countries where 209 
there are endogamous populations (e.g. Irish Travellers), with associated founder mutations 210 
and disorders[42]; and among populations where first-cousin marriage is permitted, with 211 
associated increased incidence of recessive disorders. Birth rates in the Republic of Ireland 212 
(13.5 per 1000) and Northern Ireland (13.1/1000) are higher than the reported 11.8/1000 in 213 
England, Scotland and Wales and these together with the current lack of availability of 214 
termination of pregnancy on the island of Ireland result in more urgent liveborn referrals 215 
which may impact regional differences in referral rates.  216 
The March of Dimes describes that a fundamental role of a Clinical Genetic service is 217 
prevention [43]. One component of this is to offer cascade genetic testing to at-risk relatives 218 
of patients with confirmed genetic disorders. Many referrals may therefore be generated by 219 
a single family once a pathogenic genetic variant is identified. Cascade screening is 220 
particularly burdensome in countries with large family sizes. In Ireland, the average size of 221 
an extended 3 generation family [including siblings of grandparents and their offspring] is >3 222 
times (64 vs 19) that of average families in England/Wales and Scotland (figure 4) [44, 45]. 223 
Unsurprisingly, cascade screening for common dominant genetic disorders accounts for 12% 224 
of general referrals in Ireland. Regional differences in referral rates may be further 225 
explained by differences in management of such referrals. In some centres, at risk relatives 226 
may self-refer by telephone or email. Furthermore, other relatives may opt to attend the 227 
appointment offered to one individual in the family to ͞skip the Ƌueue͟. GeŶeƌally, these 228 
patieŶts aƌe faĐilitated, ĐouŶselled aŶd tƌeated, ďut ŵay Ŷot ďe ƌeĐoƌded as a ͞ƌefeƌƌal͟. 229 
Other centres require formal referrals from GPs or secondary care to facilitate review of 230 
relatives for cascade testing.  231 
 232 
Population demographics and local policies cannot completely account for the lack of 233 
consistency within units. IŶ ĐeƌtaiŶ uŶits, geŶetiĐ ĐouŶselloƌs peƌfoƌŵ ͞pƌe-ĐliŶiĐ͟ foƌ 234 
consultants; and this may explain the variability in assignment of designated consultant. 235 
“oŵe paƌtiĐipaŶts ŵay haǀe seleĐted ͞geŶetiĐ ĐouŶselloƌ͟ ďased oŶ the fiƌst appoiŶtŵeŶt to 236 
ǁhiĐh ƌefeƌƌal ǁould ďe assigŶed, ǁhile otheƌs ŵay haǀe seleĐted ͞ĐoŶsultaŶt͟ as ƌefeƌƌal 237 
would ultimately end up in a consultant clinic. In centres where genetic counsellor staffing 238 
levels are sub-optimal, pre-clinics are not possible.   239 
In most specialties, priority is defined by urgency of the referral, which may not be 240 
appropriate in specialties like Clinical Genetics, where most referrals are non-urgent[46]. 241 
Defining priority by urgency may therefore disadvantage the majority of patients referred to 242 
Clinical Genetics[39], putting routine waiting lists under strain. There are no current 243 
guidelines one can use to determine priority of referral, although a shared set of 244 
prioritisation criteria have been proposed – including the clinical and non-clinical benefits to 245 
patient and family; risk, progression, and severity of disease, and cost, and infrastructure for 246 
testing [47, 48].  247 
In our study, it is likely that other factors, such as local waiting lists, availability of regional 248 
specialist clinics, or human subjectivity may explain the inconsistencies we have observed 249 
within each centre. Certain specific situations (e.g. if genetic diagnosis required prior to 250 
undergoing surgery, starting new treatment, accessing services etc.) may mean that cases 251 
that might otherwise be rejected or managed by letter will be offered face-to-face 252 
appointments. All centres involved in this study are training centres for Clinical Geneticists, 253 
and common conditions that might otherwise be deflected to another specialty might be 254 
accepted to fulfil curricular requirements.  255 
Limitations of this study 256 
Each individual centre faces different pressures with respect to staffing and waiting lists, 257 
which will, in turn, impact triage practice. It is possible that the process might differ in each 258 
centre when dealing with real referrals, all participants knew this was a research study and 259 
that referrals were high-fidelity simulations; participants may therefore have been more 260 
casual in their answers. We did not collect data specifically with respect to waiting times for 261 
routine or priority appointments. We note the NHS guideline of maximum 18 weeks, but 262 
appreciate that many centres in the UK struggle to avoid breaching this timeline. As a direct 263 
consequence of poor staffing levels, in the Republic of Ireland, the waiting times for priority 264 
appointments are in the order of 12-14 months, and for routine, 18-24 months. Attempts to 265 
recruit and retain trainees and genetic counsellors; and upskill non-genetic specialist is a 266 
continuing challenge.    267 
Conclusion  268 
The consensus in triage established in this paper should form the basis for guidelines to help 269 
an equitable consistent approach to these 13 common referrals. Individual centres will need 270 
to establish more standardised local policies in the context of their own staffing levels and 271 
availability of regional specialist clinics, but national/international guidelines are required to 272 
ensure equity in the triage process. We are mindful that we have examined the process with 273 
13 common referrals; ensuring consistency is likely to be even more challenging when 274 
addressing the complex referrals received by all clinical genetics service. We would suggest 275 
that this issue should be considered in a European context; possibly by convening a 276 
workshop at the European Society of Human Genetics annual meeting. 277 
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